The money you raise will help fund lifesaving research. Research is essential if we are to better understand kidney disease and develop new and improved treatments and ultimately a cure.
Our kidneys are the most amazing organ in the human body. They keep the whole body healthy and working, from the heart and skin to the bones and digestive system. They clean all your blood 40 times a day and regulate your blood pressure.
The effects of kidney disease are catastrophic – every cell in the body relies on your kidneys. There is no cure, only life prolonging treatments such as dialysis, often described as "life support with no life".
While some 5,200 people on the transplant list are waiting for a kidney, only around 3,000 transplants take place each year. For those waiting on dialysis, sometimes for years, life can be on hold.
We rely almost wholly upon supporters like you raising money to fund research projects. As a result, our research breakthroughs have given more kidney patients and their families the chance of a normal life.
Dr Rukshana Shroff and her team at Great Ormond Street Hospital may have found a simple way to improve life expectancy and quality of life for children on dialysis.
Their study has shown that a newer type of dialysis called haemodiafiltration is better for children than conventional haemodialysis.
There are hundreds of children who undergo regular dialysis. This study may lead to the eventual adoption of haemodiafiltration as the preferred type of dialysis across the UK.
A world-first breakthrough in kidney transplantation and first human trials, funded by Kidney Research UK, took place in 2012.
Professor Mike Nicholson and his team at Leicester pioneered the warm perfusion technique, which pumps oxygenated blood through donated kidneys prior to transplantation. This could reduce the transplant waiting list by 10-20%. Deborah Bakewell was the first person in the world to be given a kidney using this new technique. Deborah's story
The National Institute for Health and Care Excellence (NICE) recommended eculizumab for treating a very rare life-threatening type of kidney disease called aHUS. Kidney Research UK funded research had been central to understanding how to combat the disease. Find out more
Kidney cancer is often resistant to radiotherapy or chemotherapy making it hard to treat. Dr John Bradley and his team at Addenbrooke’s Hospital have made a remarkable discovery during a project funded by Kidney Research UK. They have identified proteins that send signals to cells. They believe that by controlling these signals it may one day be possible to instruct cells in a kidney tumour to die and stop the growth of the cancerous tumour.